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Summary
A ventricular assist device (VAD) is inserted to provide mechanical circulatory sup-
port. A VAD can rest the myocardium and allow it to recover from stunning or hibernati-
on, while maintaining vital organ perfusion (bridge-to-recovery). If myocardial recovery 
cannot occur, the goal is to support the patient to transplantation (bridge-to-transplan-
tation), or, if the patient is not a transplant candidate, to enhance the quality of life for a 
limited period of time (destination therapy).
Perioperative transesophageal echocardiography is a major component of patient 
management, and it is important for surgical and anesthetic decision-making. In addition 
to the standard examination, device-specific pre-, intra-, and postoperative considera-
tions are essential to the echocardiographic evaluation. These include: (a) the pre-VAD 
insertion examination of the heart and large vessels, in order to exclude significant aortic 
regurgitation, tricuspid regurgitation, mitral stenosis, patent foramen ovale or other car-
diac abnormality that could lead to right-to-left shunt after the left VAD placement, in-
tracardiac thrombi, ventricular scars, pulmonic regurgitation, pulmonary hypertension, 
pulmonary embolism and atherosclerotic disease in the ascending aorta; and to assess 
the right ventricular function; and (b) the post-VAD insertion examination of the device 
and reassessment of the heart and large vessels. The examination of the device aims 
to confirm the completeness of the device and heart deairing, cannulas alignment and 
patency, and the competency of the device valves using two-dimensional, and color, 
continuous and pulsed wave Doppler modalities. The goal of the heart examination af-
ter the implantation should be to exclude the aortic regurgitation or an uncovered right-
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to-left shunt, and to assess the right ventricular function, the left ventricular unloading, 
and the effect of the device settings on the global heart function.
Keywords: transesophageal echocardiography; ventricular assist device; right-to-left 
shunt; cardiopulmonary bypass.
INTRODUCTION
Over the years, the ventricular assist device (VAD) therapy has become an in-
creasing option for patients with end-stage heart failure. High implantation costs, 
as well as long postoperative length of stay in debilitated patients’ cases, make the 
VAD therapy [1-4] complicated.
In the multidisciplinary approach, the cardiac surgeons and the heart failure 
team evaluate potential VAD candidates together, starting immediately after the ad-
mission to hospital, to identify the optimal timing for the VAD implantation. Special 
attention is paid to not delaying the VAD implantation as to prevent the end-organ 
dysfunction, such as renal failure, hepatic failure and intubation.
VADs are used when pharmacological manipulations and intraaortic balloon 
pump counterpulsation fail to improve the cardiogenic shock or less severe low-
output states that are worsening. In general, VADs are pumps that collect blood 
returning to the heart and eject it downstream of the failing ventricle.
Typically, for the left ventricular support, blood is drained from the left atrium 
or the left ventricular apex to the pump, and returned to the ascending aorta. For 
the right ventricular (RV) support, blood is drained from the right atrium or the 
RV to the pump and returned to the main pulmonary artery. The goal is either to 
decompress the acutely ischemic and failing ventricle (thereby reducing its oxygen 
demand), so it can recover, or to provide a long-term support for a chronically fai-
ling ventricle as either a bridge-to-transplantation or destination therapy.
As is the case with the diseased native heart, normal or slightly increased intravas-
cular volume and normal or slightly decreased vascular resistance are necessary for the 
VADs to function optimally. Hypovolemia will delay the VAD filling with each pump 
cycle, which may decrease the overall pump output, leading thereby to hypotension.
Transesophageal echocardiography (TEE)
Transesophageal echocardiography (TEE) is an important tool in the periopera-
tive management of patients undergoing VAD implantation. TEE has been shown to 
provide critical information on the diagnosis of preinsertion abnormalities, and the 
evaluation of postinsertion function [5,6].
69
Rad 509. Medical Sciences, 36(2011) : 67-79
D. Kristović: Intraoperative transesophageal echocardiography and anesthetic considerations in patients with ...
The echocardiographic assessment of patients undergoing the VAD insertion 
involves aspects pertaining both to a general echocardiographic examination and 
to specific considerations associated with the VAD. As in most echocardiographic 
assessments, a comprenhensive examination is required [7-10].
DEfECTs CREaTINg INTRaCaRDIaC shUNTs
Patent foramen Ovale
The investigation of a Patent Foramen Ovale (PFO) should always be performed 
before and after cardiopulmonary bypass (CPB) for the implantation of a VAD. Sin-
ce a PFO is common (27,3 % in one study) [11], meticulous care should be taken to 
identify its presence.
In the pre-CPB period, the examination of the interatrial septum of the patient 
with LV failure will often show a rightward deviation [12], indicative of an increased 
LA pressure surpassing the RA pressure. Because of this factor, the investigation of 
a PFO with color Doppler echocardiography may clearly show a left-to-right shunt. 
The TEE assessment for a PFO after the VAD insertion can be started early, while 
weaning from the CPB, and a PFO can be potentially detected even before complete 
separation. Early detection is important, as the presence of a PFO requires the re-
turn to a CPB for closure.
Other septal abnormalities
Traumatic atrial septal defects (fossa ovalis) can occur intraoperatively and also 
produce profound hypoxemia in the setting of increased right-to-left atrial pressure 
gradient with the LVAD support [13].
Fig. 1: Mid-esophageal two-chamber view, showing dilated overloaded left ventricle in a 
patient with dilated cardiomyopathy.
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Finally, ventricular septal defects, particulary postinfarct, are a potential cause 
of significant shunting, before and after the VAD placement.
ValVUlaR aND asCENDINg aORTIC DEfECTs
aortic valve
Normal functioning of the LVAD during full support usually prevents the sy-
stolic opening of the native or prosthetic aortic valve, given the increase in the aor-
tic-to-LV pressure gradient, due to the suction of the blood from the LV through the 
inflow cannula and its propulsion into the aorta through the outflow cannula.
Fig. 2: Mid-esophageal short (SAX) and long axis view (LAX), showing normal aortic valve in 
the preinsertion period.
Aortic Insufficiency
The diagnosis of significant pre- and postoperative Aortic Insufficiency (AI) is 
crucial in patients receiving an LVAD. The presence of AI reduces the forward flow 
produced by the LVAD, due to the regurgitation of the LVAD-supported flow into the 
LV cavity. Aortic competence should also be assessed during the CPB by intraoperati-
ve TEE, before the insertion of the LVAD [14], when transvalvular gradients are closer 
to those to be observed after the LVAD insertion. The identification of severe and, 
possibly, moderate AI should indicate the need for surgical correction [15].
In patients with no previous aortic insufficiency, the incidence of AI after the 
LVAD insertion is low [16], and it may become present months later [17, 18]. Mecha-
nisms producing the post-LVAD AI include endocarditis [19], aortic dissection [20, 
21], and aortic leaflet prolapse or perforation.
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aortic stenosis
Preoperative Aortic Stenosis (AS) is usually not critical to LVAD recipients, since 
pulsatile devices typically generate full cardiac output and, thus, the systemic blood 
flow does not depend on antegrade flow through the aortic valve. In VADs that pro-
vide partial or variable support, such as axial flow devices, the intermittent opening 
of the aortic valve occurs and contributes to a global cardiac output. Consequently, 
patients with severe AS may not be good candidates for such devices.
ascending aorta
The ascending aorta should be examined to detect abnormalities before perfor-
ming the end-to-side anastomosis of the outflow cannula. A mid-esophageal (ME) 
ascending aortic long-axis view should be used to locate and classify the structural 
abnormalities in the ascending aorta. The aortic arch and the descending aorta sho-
uld be assessed with the same goal. Atheromata with thickness > 5 mm and/or pro-
truding and/or mobile components are associated with an increased risk of cerebral 
embolic events during the cardiac surgery.
Tricuspid Regurgitation
Functional Tricuspid Regurgitation (TR) is a common finding in patients with 
heart failure. Adequate RV function is essential after an LVAD insertion to optimize 
the LVAD filling. The presence of significant postoperative TR can significantly con-
tribute to the RV dysfunction and the development of a low output state. Given that 
LVAD insertion produces the unloading of the LV and a decrease in the PA pressure, 
it might be expected that TR would be reduced post-insertion. Some authors have 
found this true, but not others, who reported an acute worsening in TR after the 
LVAD insertion. The fact that an isolated implantation of an LVAD does not produ-
ce a consistent change in the degree of perioperative TR is likely associated with a 
combination of factors, including the leftward shift of the interventricular septum, 
produced by the LVAD; an increase in the PA pressure and the RV dysfunction due 
to the inflammatory response to surgery, CPB and blood transfusion; and an incre-
ase in preload to the RV due to an increased left-sided output, delivered by a fun-
ctioning LVAD in lieu of the previously failing left heart. Leftward interventricular 
septal shift is more pronounced in LVAD patients, who are hypovolemic and have 
higher VADs flows.
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Functional Mitral Regurgitation (MR) is a significant and common complicati-
on of end-stage heart failure and cardiomyopathy [22,23]. A central jet on the color 
Doppler image, which has been reported to be of at least moderate severity in 39 
% of the patients in a retrospective study of patients with advanced systolic heart 
failure, characterizes this form of MR. The insertion of a LVAD leads to reduced LV 
size, an improved coaptation of the mitral valve leaflets and, ultimately, a decreased 
preexisting MR. The persistence of significant MR post-LVAD insertion may indica-
te inadequate LV decompression.
Mitral stenosis
Mitral Stenosis (MS) is a rare finding in patients scheduled for an LVAD inser-
tion. Significant MS restricts the filling of the LVAD, leading to low device output 
and, consequently, to low cardiac output. RV failure can also occur due to increased 
pulmonary vascular resistance (PVR).
Pulmonic Valve
Pulmonic valve lesions are relatively rare in patients receiving a VAD. Pulmonic 
insufficiency more than moderate would be an important finding in those patients. 
Fig. 3: Massive tricuspid regurgitation after the LVAD insertion.
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The RV dysfunction is a well-recognized and serious condition that may occur 
in LVAD recipients. As the output of the native RV determines the preload of the 
LVAD [24], a decrease in RV function will translate into a reduction in the LVAD 
output. Reports suggest that at least 9-33 % of patients suffer severe RV failure after 
the LVAD insertion [25-30] and may require an RVAD. This decision is often needed 
when a CPB is discontinued, because the RVAD insertion should be performed early 
after the development of severe RV failure following LVAD implantation.
Left Ventricle
The evaluation of the LV function pre-LVAD insertion will show depressed fun-
ction with either a dilated or normal size ventricle, depending on the cause of heart 
failure. The LV ejection fraction (LVEF) for LVAD insertion is typically <25-30 %. 
Significant diastolic dysfunction is also usually present and diagnosed with PW Do-
ppler of the transmitral inflow, combined with PW Doppler of the pulmonary veins 
or with tissue Doppler. Severe LV dysfunction increases the risk of apical thrombus 
formation. Apical thrombus, when present, is often located near the inflow cannu-
la insertion site. Thus, the preoperative interrogation of the LV for the presence of 
thrombus is an essential part of the echocardiographic examination.
ThE assEssMENT Of VaD COMPONENTs
Cannula position
Inflow cannula. The inflow cannulas and their orientation within the RA, the 
LA or the ventricles can be visualized on two-dimension imaging. The inflow ca-
nnula to an LVAD may originate from the LA or the LV. The most common origin 
is the apex of the LV and, in this case, the cannula should be aligned with the LV 
inflow tract, i.e. with the mitral valve opening, and not abutting any wall.
Outflow cannula. The outflow cannula for an LVAD or an RVAD is visualized 
with two-dimensional imaging. A long axis view of the ascending aorta at the level 
of the right PA will usually show the outflow cannula anastomosis to the ascending 
aorta. The ascending aorta should also be checked for the presence of calcification, 
plaque, or dilation, which could modify the placement of the cannula.
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Thromboemboli
The presence of intracavitary thrombi requires extra care during cannulation, as 
there is a risk of embolism. The incidence of thromboembolic complications after the 
LVAD support varies significantly in different reports between 5 % and 47 %. The 
use of TEE allows for the identification of mobile LV thrombi adjacent to the LVAD 
inflow cannula, and the LV outflow tract.
Anesthetic Considerations in Patients with Ventricular Assist Devices
In the end stage of cardiac failure, patients inevitably have mild to severe pul-
monary hypertension and may be on chronic inodilator therapy with dobutamine 
Fig. 4: The alignment of the left ventricular assist device (LVAD) inflow cannula, mid-esopha-
geal four-chamber view (A). The ideal axial alignment will optimize blood flow to assist the 
device. A small angle is observed between axes for the two-chamber view (B).
LA = left atrium; LV = left ventricle.
Fig. 5: (A) Echodense structure at the inlet of the inflow cannula compatible with a thrombus. 
The obstruction of the inflow cannula can produce an increase in the velocity at the inflow 
cannula (B). LA = left atrium; LV = left ventricle.
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and/or milrinone; they furthermore suffer from substantial hepatic, renal and pul-
monary insufficiency. Some may have an IABP in place and be already mechanically 
ventilated or on intermittent or continuous hemodialysis. Many of these patients are 
reops (prior coronary revascularization, valve surgery, AICD), and require therefore 
the anticipation of major bleeding and/or the incision of vital structures during ope-
ning, dissection and cannulation.
In anticipation of the potential for massive blood loss, large bore central venous 
access is obtained together with pulmonary artery catheterization. A rapid infusion 
blood-warming device is primed to ensure the ability to give fully warmed blood 
and blood products at the volumes of 250-1000 mL/min. Blood and blood products 
(e.g. 6 units of packed red blood cells, 6 units of fresh frozen plasma, 12 units of 
platelets) are readied in preparation for post-CPB coagulopathy. Early transfusion 
may reverse factor deficiency before vicious cycles (bleeding → DIC → bleeding) 
develop.
The anesthetic regimen should acknowledge the tenuous hemodynamic state 
and compromised drug elimination capacity of these patients; for example, cisatra-
curium should be used instead of vecuronium.
Aprotinin, a kallikrein and serine protease inhibitor, which has antifibrinolytic 
and platelet sparing effects on the CPB, may be used, as it has been proven to decrea-
se the blood loss, the blood requirement and perioperative mortality. Some advocate 
priming the CPB circuit with fresh frozen plasma to decrease the dilution of clotting 
factors in patients with preoperative coagulopathy, and maintain the levels of antit-
hrombin III, avoiding thereby consumptive coagulopathy.
Transesophageal echocardiography (TEE) is essential not only to monitor the LV 
filling and the RV function throughout the case, but also to exclude the presence of 
an atrial septal defect (ASD), the patent foramen ovale (PFO), aortic regurgitation or 
mitral stenosis. These lesions must be repaired prior to the separation from the CPB; 
with an ASD or a PFO, a right-to-left shunt may commence, as the left-sided filling 
pressures are decreased when the LVAD support begins.
Adequate LVAD output during the separation from the CPB requires aggressive 
volume loading, since the LVAD decompresses the LV and the left atrium. The RV 
dysfunction is treated with inodilator drugs (milrinone, dobutamine), whilst exce-
ssive systemic vasodilatation, causing systemic hypotension, is treated with norepi-
nephrine and/or vasopressin. Severe pulmonary hypertension may induce an acute 
RV failure and responds well to inhaled nitric oxide, 10-20 ppm, which has marked-
ly decreased the requirement for emergency placement of an RVAD to come off the 
CPB in the OR.
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Sažetak
Intraoperacijski TEE i anesteziološko liječenje bolesnika s mehaničkom potporom srca
Uređaj za mehaničku potporu srcu (eng. VAD) se ugrađuje radi pružanja mehaničke potpore 
srcu i cirkulaciji. Njime se osigurava oporavak miokarda nakon stunninga i hibernacije, i u isto 
vrijeme održava perfuzija vitalnih organa (eng. bridge-to-recovery). Ukoliko se miokard ne može 
oporaviti od oštećenja tada je cilj  ovakve terapije pružiti potporu bolesniku do trenutka tran-
splantacije srca (eng. bridge-to-transplantation), ili ukoliko bolesnik nije pogodan za transplanta-
ciju, poboljšati mu kvalitetu života u ograničenom vremenu (ciljna terapija).
Perioperacijski TEE je glavna metoda u liječenju i nadziranju takvih bolesnika koja pruža 
brojne informacije i kirurgu i anesteziologu, olakšavajući pri tom donošenje važnih terapijskih 
odluka. Uz osnovni standardni pregled, za ehokardiografsku procjenu su važni i za uređaj speci-
fični pre-, intra- i postoperacijski ehokardiografski pregled. To uključuje: (a) pregled srca i velikih 
krvnih žila prije postavljanja VAD uređaja, kako bi se isključila značajnija aortna regurgitacija, 
trikuspidna regurgitacija, mitralna stenoza, otvoreni foramen ovale i druge abnormalnosti koje bi 
mogle dovesti do D-L shunt-a nakon postavljanja VAD-a, stvaranja intrakardijalnih tromba, ven-
trikulskih ožiljaka, plućne regurgitacije i hipertenzije, plućne embolije i aterosklerotske bolesti u 
uzlaznoj aorti. Važno je i procijeniti funkciju desnog ventrikula, i (b) pregled uređaja nakon po-
stavljanja VAD-a i ponovna procjena srca i velikih krvnih žila. Cilj pregleda uređaja je potvrditi 
ispravnost uređaja, izvršenog srčanog odzračivanja; potvrditi ispravan položaj kanila i njihovu 
prohodnost, kompetentnost valvula i to uporabom dvodimenzionalnog, obojenog, kontinuira-
nog i pulsnog doplera. Cilj pregleda srca nakon implantacije je isključiti aortnu regurgitaciju ili 
neprepoznati D-L shunt, i procijeniti funkciju desnog ventrikla, odterećenost lijevog ventrikla i 
općenito učinak različitih podešavanja uređaja na globalnu srčanu funkciju.
Ključne riječi: transezofagusna ehokardiografija; uređaj za mehaničku potporu; desno-lijevi 
shunt (D-L); izvantjelesni krvotok

